Canadian pancreatic cancer specialist expects to open clinical trials on pill that doubled survival time (Business)

The head of pancreatic cancer at Princess Margaret Cancer Centre says she hopes clinical trials for a pill that could double survival time will soon be open to Canadian patients. Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and...

Go to News Site